Cargando…

New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway

Two series of novel amino acid Schiff base ligands containing heterocyclic moieties, such as quinazolinone 3–11 and indole 12–20 were successfully synthesized and confirmed by spectroscopic techniques and elemental analysis. Furthermore, all compounds were investigated in silico for their ability to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noser, Ahmed A., Abdelmonsef, Aboubakr H., El-Naggar, Mohamed, Salem, Maha M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434356/ https://www.ncbi.nlm.nih.gov/pubmed/34500765 http://dx.doi.org/10.3390/molecules26175332

Ejemplares similares

Synthesis, In Silico and In Vitro Assessment of New Quinazolinones as Anticancer Agents via Potential AKT Inhibition
por: Noser, Ahmed A., et al.
Publicado: (2020)

Newly Synthesized Pyrazolinone Chalcones as Anticancer Agents via Inhibiting the PI3K/Akt/ERK1/2 Signaling Pathway
por: Noser, Ahmed A., et al.
Publicado: (2022)

Synthesis, Molecular Docking Studies and In Silico ADMET Screening of New Heterocycles Linked Thiazole Conjugates as Potent Anti-Hepatic Cancer Agents
por: Rashdan, Huda R. M., et al.
Publicado: (2021)

Current development of the second generation of mTOR inhibitors as anticancer agents
por: Zhou, Hong-Yu, et al.
Publicado: (2012)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

Mesoglycan attenuates VSMC proliferation through activation of AMP-activated protein kinase and mTOR
por: Lee, Kyung Young, et al.
Publicado: (2016)

Cyclization of Chalcone Derivatives: Design, Synthesis, In Silico Docking Study, and Biological Evaluation of New Quinazolin-2,4-diones Incorporating Five-, Six-, and Seven-Membered Ring Moieties as Potent Antibacterial Inhibitors
por: El-Naggar, Mohamed, et al.
Publicado: (2023)

Double agent mTOR
por: Danzer, Steve C.
Publicado: (2019)

Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway
por: Wu, Hongyan, et al.
Publicado: (2019)

Synthesis, Characterization, Antibacterial Activity, and Computer-Aided Design of Novel Quinazolin-2,4-dione Derivatives as Potential Inhibitors Against Vibrio cholerae
por: El-Naggar, Mohamed, et al.
Publicado: (2020)

mTOR signaling: implications for cancer and anticancer therapy
por: Petroulakis, E, et al.
Publicado: (2006)

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
por: Storozhuk, Yaryna, et al.
Publicado: (2012)

Adipose triglyceride lipase activity regulates cancer cell proliferation via AMP-kinase and mTOR signaling
por: Xie, Hao, et al.
Publicado: (2020)

Eco-Friendly Synthesis, Biological Evaluation, and In Silico Molecular Docking Approach of Some New Quinoline Derivatives as Potential Antioxidant and Antibacterial Agents
por: El-Saghier, Ahmed M., et al.
Publicado: (2021)

Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and in silico Molecular Docking Studies
por: Haredi Abdelmonsef, Aboubakr, et al.
Publicado: (2020)

Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect
por: Lu, Chung-Ling, et al.
Publicado: (2015)

A conjugated mTOR/MEK bifunctional inhibitor as potential polypharmacological anticancer agent: the prototype compound discovery
por: Tao, Qiangqiang, et al.
Publicado: (2020)

Synthesis of Amino Acid Schiff Base Nickel (II) Complexes as Potential Anticancer Drugs In Vitro
por: Li, Yang, et al.
Publicado: (2020)

Synthesis, Molecular Docking Analysis and in Vitro Biological Evaluation of Some New Heterocyclic Scaffolds-Based Indole Moiety as Possible Antimicrobial Agents
por: Hassan, Entesar A., et al.
Publicado: (2022)

Bioactive Salen-type Schiff Base Transition Metal Complexes as Possible Anticancer Agents
por: Damercheli, Maryam, et al.
Publicado: (2019)

Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS/PI3K/Akt/JNK inhibition in breast carcinoma cells
por: Salem, Maha M., et al.
Publicado: (2022)

Mechanisms of amino acid sensing in mTOR signaling pathway
por: Kim, Eunjung
Publicado: (2009)

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR
por: Lee, Boah, et al.
Publicado: (2022)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

Porphyrin–Schiff Base Conjugates Bearing Basic Amino Groups as Antimicrobial Phototherapeutic Agents
por: Pérez, María E., et al.
Publicado: (2021)

Amino acid primed mTOR activity is essential for heart regeneration
por: Miklas, Jason W., et al.
Publicado: (2021)

Vitamin D Modulation of Mitochondrial Oxidative Metabolism and mTOR Enforces Stress Adaptations and Anticancer Responses
por: Quigley, Mikayla, et al.
Publicado: (2021)

Chemical and Structural Strategies to Selectively Target mTOR Kinase
por: Borsari, Chiara, et al.
Publicado: (2021)

Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway
por: Li, Zhengkun, et al.
Publicado: (2014)

In silico study to identify novel potential thiadiazole-based molecules as anti-Covid-19 candidates by hierarchical virtual screening and molecular dynamics simulations
por: Rashdan, Huda R. M., et al.
Publicado: (2022)

Screening, Synthesis, and QSAR Research on Cinnamaldehyde-Amino Acid Schiff Base Compounds as Antibacterial Agents
por: Wang, Hui, et al.
Publicado: (2018)

Synthesis, Identification, Computer-Aided Docking Studies, and ADMET Prediction of Novel Benzimidazo-1,2,3-triazole Based Molecules as Potential Antimicrobial Agents
por: Rashdan, Huda R. M., et al.
Publicado: (2021)

Distinct amino acid–sensing mTOR pathways regulate skeletal myogenesis
por: Yoon, Mee-Sup, et al.
Publicado: (2013)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Chiral Pyridine-3,5-bis- (L-phenylalaninyl-L-leucinyl) Schiff Base Peptides as Potential Anticancer Agents: Design, Synthesis, and Molecular Docking Studies Targeting Lactate Dehydrogenase-A
por: Amr, Abd El-Galil E., et al.
Publicado: (2020)

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
por: Mercer, Paul F, et al.
Publicado: (2016)

Targeting mTOR for the treatment of AML. New agents and new directions
por: Altman, Jessica K., et al.
Publicado: (2011)

mTOR inhibitors: A novel class of anti-cancer agents
por: Riaz, Haris, et al.
Publicado: (2012)

Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target
por: Ferreira, Juliana C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ublg2qh691gafmgkkcniskddef